In order to request this CME/CE activity for your center, please contact Samantha Zelasko at SZelasko@gotoper.com

November 14, 2024 | 12:00 – 1:00 PM ET

Register Here

November 20, 2024 | 12:00 – 1:00 PM ET

Register Here

December 9, 2024 | 12:00 - 1:00 PM ET

Register Here

December 19, 2024 | 10:00 - 11:00 AM ET

Register Here

HER2 has become an important target of interest for patients with metastatic colorectal cancer in recent years, with research efforts culminating in successful clinical trials and a first drug approval in 2023. The goal of this Oncology Best Practice™ series is to provide up-to-date recommendations for testing, treatment selection, and management of toxicities related to patients with HER2-positive metastatic colorectal cancer. This series of live, virtual meetings will include multiple formats for learning, including data presentations, case presentations, and faculty Q&A.

This educational activity is directed toward oncology healthcare professionals who treat or manage patients with colorectal cancer.

Upon completion of this activity, participants will be able to:

• Determine the frequency of HER2 alterations in metastatic colorectal cancer (mCRC), characteristics of HER2+ tumors, and implications for treatment
• Evaluate data from clinical trials investigating HER2-targeted therapies for the treatment of HER2+ mCRC
• Develop proactive strategies to facilitate the identification and management of adverse events associated with HER2-targeted therapies in patients with metastatic HER2+ CRC
• Integrate biomarker testing and evidence-based, guideline-directed therapies to manage real-world case scenarios encountered in the care of patients with HER2+ advanced/metastatic CRC

Tanios Bekaii-Saab, MD

Professor, Mayo Clinic College of Medicine and Science
Director, Cancer Research Office, Mayo Clinic Cancer Center
Program Leader, Gastrointestinal Cancer, Mayo Clinic Cancer Center
Consortium Chair, ACCRU
Vice-Chair and Section Lead, Division of Medical Oncology
Consultant, Mayo Clinic
Phoenix, AZ

Physicians’ Education Resource^®, LLC, is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Physicians’ Education Resource^®, LLC designates this live activity for a maximum of 1.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

This activity is supported by an educational grant from Seagen Inc.